Bio-Techne Corp (TECH)
71.28
+0.23
(+0.32%)
USD |
NASDAQ |
Nov 22, 16:00
71.28
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Shareholders Equity (Quarterly): 2.139B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.139B |
June 30, 2024 | 2.069B |
March 31, 2024 | 2.014B |
December 31, 2023 | 1.964B |
September 30, 2023 | 1.998B |
June 30, 2023 | 1.967B |
March 31, 2023 | 1.890B |
December 31, 2022 | 1.827B |
September 30, 2022 | 1.751B |
June 30, 2022 | 1.702B |
March 31, 2022 | 1.714B |
December 31, 2021 | 1.703B |
September 30, 2021 | 1.639B |
June 30, 2021 | 1.563B |
March 31, 2021 | 1.539B |
December 31, 2020 | 1.522B |
September 30, 2020 | 1.439B |
June 30, 2020 | 1.381B |
March 31, 2020 | 1.291B |
December 31, 2019 | 1.323B |
September 30, 2019 | 1.174B |
June 30, 2019 | 1.166B |
March 31, 2019 | 1.146B |
December 31, 2018 | 1.096B |
September 30, 2018 | 1.109B |
Date | Value |
---|---|
June 30, 2018 | 1.079B |
March 31, 2018 | 1.058B |
December 31, 2017 | 997.82M |
September 30, 2017 | 959.81M |
June 30, 2017 | 949.63M |
March 31, 2017 | 907.92M |
December 31, 2016 | 890.57M |
September 30, 2016 | 895.40M |
June 30, 2016 | 879.28M |
March 31, 2016 | 852.96M |
December 31, 2015 | 856.34M |
September 30, 2015 | 837.95M |
June 30, 2015 | 846.94M |
March 31, 2015 | 820.07M |
December 31, 2014 | 820.68M |
September 30, 2014 | 793.41M |
June 30, 2014 | 795.26M |
March 31, 2014 | 777.04M |
December 31, 2013 | 748.53M |
September 30, 2013 | 726.76M |
June 30, 2013 | 737.54M |
March 31, 2013 | 719.51M |
December 31, 2012 | 694.56M |
September 30, 2012 | 680.60M |
June 30, 2012 | 674.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.291B
Minimum
Mar 2020
2.139B
Maximum
Sep 2024
1.722B
Average
1.709B
Median
Shareholders Equity (Quarterly) Benchmarks
Bio-Rad Laboratories Inc | 7.488B |
Boston Scientific Corp | 20.71B |
ResMed Inc | 5.195B |
Zimmer Biomet Holdings Inc | 12.37B |
AIM ImmunoTech Inc | 2.912M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.736B |
Total Liabilities (Quarterly) | 597.37M |
Debt to Equity Ratio | 0.1403 |
Current Ratio | 4.563 |
Net Debt Paydown Yield | 0.08% |